Literature DB >> 21259232

Effect of postconditioning on mitochondrial dysfunction in experimental aortic cross-clamping.

A-L Charles1, A-S Guilbert, J Bouitbir, P Goette-Di Marco, I Enache, J Zoll, F Piquard, B Geny.   

Abstract

BACKGROUND: Cross-clamping of the aorta during abdominal aortic aneurysm surgery induces muscle ischaemia with resultant morbidity. This study tested whether ischaemic postconditioning would decrease mitochondrial dysfunction in skeletal muscle by reducing oxidative stress.
METHODS: Three groups (9 rats each) underwent surgery, including a control group without ischaemia and an ischaemia-reperfusion group that had 3 h ischaemia induced by aortic clamping and collateral vessel ligation, followed by 2 h of reperfusion. The third group had ischaemia for 3 h then underwent postconditioning comprising three short intervals of ischaemia-reperfusion at the onset of reperfusion. Activity of complexes I, II, III and IV of the mitochondrial respiratory chain was monitored in gastrocnemius muscle, along with oxidative stress measured by dihydroethidium (DHE) staining and antioxidant defence determined by measurement of glutathione levels.
RESULTS: Ischaemia-reperfusion alone caused a significant reduction in maximal oxidative capacity (-31.8 per cent; P = 0.002), activity of complexes II, III and IV (-34.5 per cent; P = 0.007) and complex IV activity (-30.6 per cent; P = 0.039). It also increased reactive oxygen species (DHE staining increased to 223.1 per cent of control value; P = 0.027) and reduced antioxidant defence (glutathione level -28.6 per cent; P = 0.039). Postconditioning counteracted these deleterious effects by increasing mitochondrial complex I, II, III and IV activities, restoring muscle DHE staining and preserving glutathione content.
CONCLUSION: Ischaemic postconditioning protects skeletal muscle mitochondria against ischaemia-reperfusion injury by reducing oxidative stress and preserving antioxidant defence in an experimental model. Mitochondrial protection to reduce reperfusion injury in clinical vascular surgery may be warranted.
Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21259232     DOI: 10.1002/bjs.7384

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  18 in total

1.  Embolization of arterial gastric supply in obesity (EMBARGO): an endovascular approach in the management of morbid obesity. proof of the concept in the porcine model.

Authors:  Michele Diana; Raoul Pop; Rémy Beaujeux; Bernard Dallemagne; Peter Halvax; Isabel Schlagowski; Yu-Yin Liu; Pierre Diemunsch; Bernard Geny; Veronique Lindner; Jacques Marescaux
Journal:  Obes Surg       Date:  2015-03       Impact factor: 4.129

2.  Skeletal muscle post-conditioning by diazoxide, anti-oxidative and anti-apoptotic mechanisms.

Authors:  Mehdi Moghtadaei; Rouhollah Habibey; Marjan Ajami; Mansoureh Soleimani; Soltan Ahmed Ebrahimi; Hamidreza Pazoki-Toroudi
Journal:  Mol Biol Rep       Date:  2012-10-09       Impact factor: 2.316

Review 3.  Regulation of mitochondria function by natriuretic peptides.

Authors:  Mark Domondon; Anna B Nikiforova; Kristine Y DeLeon-Pennell; Daria V Ilatovskaya
Journal:  Am J Physiol Renal Physiol       Date:  2019-09-11

Review 4.  Effects of cyclic nucleotide phosphodiesterases (PDEs) on mitochondrial skeletal muscle functions.

Authors:  Liliane Tetsi; Anne-Laure Charles; Stéphanie Paradis; Anne Lejay; Samy Talha; Bernard Geny; Claire Lugnier
Journal:  Cell Mol Life Sci       Date:  2016-12-30       Impact factor: 9.261

5.  Iron Oxide Nanoparticles Induce Dopaminergic Damage: In vitro Pathways and In Vivo Imaging Reveals Mechanism of Neuronal Damage.

Authors:  Syed Z Imam; Susan M Lantz-McPeak; Elvis Cuevas; Hector Rosas-Hernandez; Serguei Liachenko; Yongbin Zhang; Sumit Sarkar; Jaivijay Ramu; Bonnie L Robinson; Yvonne Jones; Bobby Gough; Merle G Paule; Syed F Ali; Zbigniew K Binienda
Journal:  Mol Neurobiol       Date:  2015-10       Impact factor: 5.590

Review 6.  Resolution of Inflammation after Skeletal Muscle Ischemia-Reperfusion Injury: A Focus on the Lipid Mediators Lipoxins, Resolvins, Protectins and Maresins.

Authors:  Cindy Barnig; Gaetan Lutzweiler; Margherita Giannini; Anne Lejay; Anne-Laure Charles; Alain Meyer; Bernard Geny
Journal:  Antioxidants (Basel)       Date:  2022-06-20

Review 7.  Chronology of mitochondrial and cellular events during skeletal muscle ischemia-reperfusion.

Authors:  Stéphanie Paradis; Anne-Laure Charles; Alain Meyer; Anne Lejay; James W Scholey; Nabil Chakfé; Joffrey Zoll; Bernard Geny
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-13       Impact factor: 4.249

8.  Pressure overload-induced mild cardiac hypertrophy reduces left ventricular transmural differences in mitochondrial respiratory chain activity and increases oxidative stress.

Authors:  Michel Kindo; Sébastien Gerelli; Jamal Bouitbir; Anne-Laure Charles; Joffrey Zoll; Tam Hoang Minh; Laurent Monassier; Fabrice Favret; François Piquard; Bernard Geny
Journal:  Front Physiol       Date:  2012-08-28       Impact factor: 4.566

9.  Tetrahydrocannabinol induces brain mitochondrial respiratory chain dysfunction and increases oxidative stress: a potential mechanism involved in cannabis-related stroke.

Authors:  Valérie Wolff; Anna-Isabel Schlagowski; Olivier Rouyer; Anne-Laure Charles; François Singh; Cyril Auger; Valérie Schini-Kerth; Christian Marescaux; Jean-Sébastien Raul; Joffrey Zoll; Bernard Geny
Journal:  Biomed Res Int       Date:  2015-01-14       Impact factor: 3.411

10.  Age modulates Fe3O4 nanoparticles liver toxicity: dose-dependent decrease in mitochondrial respiratory chain complexes activities and coupling in middle-aged as compared to young rats.

Authors:  Yosra Baratli; Anne-Laure Charles; Valérie Wolff; Lotfi Ben Tahar; Leila Smiri; Jamal Bouitbir; Joffrey Zoll; Mohsen Sakly; Cyril Auger; Thomas Vogel; Hafedh Abdelmelek; Olfa Tebourbi; Bernard Geny
Journal:  Biomed Res Int       Date:  2014-05-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.